Cite
HARVARD Citation
El Dika, I. et al. (2020). Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib. Cancer medicine. pp. 7453-7459. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
El Dika, I. et al. (2020). Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib. Cancer medicine. pp. 7453-7459. [Online].